AAAAAA

   
Results: 1-25 | 26-50 | 51-71
Results: 1-25/71
FAVORABLE OUTCOME OF OVARIAN GERM-CELL MALIGNANCIES TREATED WITH CISPLATIN OR CARBOPLATIN BASED CHEMOTHERAPY - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY
Authors: DIMOPOULOS MA PAPADOPOULOU M ANDREOPOULOU E PAPADIMITRIOU C PAVLIDIS N ARAVANTINOS G ASPROPOTAMITIS A FOUNTZILAS G MICHALAS S PECTASIDES D
Citation: Ma. Dimopoulos et al., FAVORABLE OUTCOME OF OVARIAN GERM-CELL MALIGNANCIES TREATED WITH CISPLATIN OR CARBOPLATIN BASED CHEMOTHERAPY - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, European journal of cancer, 34, 1998, pp. 103-103
PRIMARY EXTRANODAL NON-HODGKINS-LYMPHOMA OF THE HEAD AND NECK IN ADULTS - A CLINICOPATHOLOGICAL COMPARISON BETWEEN TONSILLAR LYMPHOMAS
Authors: ECONOMOPOULOS T FOUNTZILAS G KOSTOUROU A DANIILIDIS J PAVLIDIS N NICOLAOU A MALLOU S DERVENOULAS J STATHAKIS M
Citation: T. Economopoulos et al., PRIMARY EXTRANODAL NON-HODGKINS-LYMPHOMA OF THE HEAD AND NECK IN ADULTS - A CLINICOPATHOLOGICAL COMPARISON BETWEEN TONSILLAR LYMPHOMAS, European journal of cancer, 34, 1998, pp. 116-116
DO LH-RH ANALOGS INDUCE EFFECTS SIMILAR TO TAMOXIFEN ON SERUM-LIPID PARAMETERS IN PREMENOPAUSAL WOMEN WITH BREAST-CANCER - A PROSPECTIVE-STUDY
Authors: ELISAF M BAIRAKTARI E NICOLAIDES C FOUNTZILAS G TZALLAS C TSOLAS O SIAMOPOULOS K PAVLIDIS N
Citation: M. Elisaf et al., DO LH-RH ANALOGS INDUCE EFFECTS SIMILAR TO TAMOXIFEN ON SERUM-LIPID PARAMETERS IN PREMENOPAUSAL WOMEN WITH BREAST-CANCER - A PROSPECTIVE-STUDY, NMCD. Nutrition Metabolism and Cardiovascular Diseases, 8(2), 1998, pp. 101-105
FIRST-LINE CHEMOTHERAPY WITH PACLITAXEL BY 3-HOUR INFUSION AND CARBOPLATIN IN ADVANCED BREAST-CANCER (FINAL REPORT) - A PHASE-II STUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP
Authors: FOUNTZILAS G DIMOPOULOS AM PAPADIMITRIOU C KALOGERAFOUNTZILA A ARAVANTINOS G BAFALOAKOS D ATHANASSIADES A NICOLAIDES C KERAMOPOULOS A PAVLIDIS N KOSMIDIS P SKARLOS D
Citation: G. Fountzilas et al., FIRST-LINE CHEMOTHERAPY WITH PACLITAXEL BY 3-HOUR INFUSION AND CARBOPLATIN IN ADVANCED BREAST-CANCER (FINAL REPORT) - A PHASE-II STUDY CONDUCTED BY THE HELLENIC COOPERATIVE ONCOLOGY GROUP, Annals of oncology, 9(9), 1998, pp. 1031-1034
DOCETAXEL (D) AND GEMCITABINE (G) IN ANTHRACYCLINE-RESISTANT ADVANCEDBREAST-CANCER (AR-ABC)
Authors: FOUNTZILAS G BAFALOUKOS D NIKOLAIDES C ARAVANTINOS G STATHOPOULOS G APOSTOLIDOU K KALOFONOS H KOSMIDIS P PAVLIDIS N
Citation: G. Fountzilas et al., DOCETAXEL (D) AND GEMCITABINE (G) IN ANTHRACYCLINE-RESISTANT ADVANCEDBREAST-CANCER (AR-ABC), Annals of oncology, 9, 1998, pp. 121-121
COMBINATION PACLITAXEL PLUS CARBOPLATIN VERSUS PACLITAXEL WITH ALTERNATING CARBOPLATIN AND CISPLATIN AS FIRST LINE TREATMENT FOR ADVANCED OVARIAN-CANCER (AOC)
Authors: ARAVANTINOS G FOUNTZILAS G KOSMIDES P STATHOPOULOS GP PAVLIDIS N DIMOPOULOS MA BAFALOUKOS D PAPAKOSTAS P PAPADIMITRIOU C NIKOLAIDES G SKARLOS DV
Citation: G. Aravantinos et al., COMBINATION PACLITAXEL PLUS CARBOPLATIN VERSUS PACLITAXEL WITH ALTERNATING CARBOPLATIN AND CISPLATIN AS FIRST LINE TREATMENT FOR ADVANCED OVARIAN-CANCER (AOC), Annals of oncology, 9, 1998, pp. 316-316
FAVORABLE OUTCOME OF OVARIAN GERM-CELL MALIGNANCIES TREATED WITH CISPLATIN OR CARBOPLATIN-BASED CHEMOTHERAPY
Authors: DIMOPOULOS MA PAPADOPOULOU M ANDREOPOULOU E PAPADIMITRIOU C PAVLIDIS N ARAVANTINOS G ASPROPORAMITIS A ANAGNOSTOPOULOS A FOUNTZILAS G ATHANASSIADES P PECTACIDES D
Citation: Ma. Dimopoulos et al., FAVORABLE OUTCOME OF OVARIAN GERM-CELL MALIGNANCIES TREATED WITH CISPLATIN OR CARBOPLATIN-BASED CHEMOTHERAPY, Annals of oncology, 9, 1998, pp. 343-343
RANDOMIZED COMPARISON OF EARLY VS LATE TWICE-DAILY CHEST IRRADIATION CONCURRENTLY WITH CHEMOTHERAPY IN LIMITED DISEASE SMALL-CELL LUNG-CANCER (LD,SCLC)
Authors: SAMANTAS E FOUNTZILAS G PANOUSSAKI E BRIASOULIS E PAVLIDIS N KALOFONOS G KARDAMAKIS D TSIAKOPOULOS E PALAMIDAS F SKARLOS D
Citation: E. Samantas et al., RANDOMIZED COMPARISON OF EARLY VS LATE TWICE-DAILY CHEST IRRADIATION CONCURRENTLY WITH CHEMOTHERAPY IN LIMITED DISEASE SMALL-CELL LUNG-CANCER (LD,SCLC), Annals of oncology, 9, 1998, pp. 405-405
PHASE-I TRIAL AND PHARMACOKINETICS OF BETA-D-GLUCOSYLISOPHOSPHORAMIDEMUSTARD (D-19575) ADMINISTERED AS A 6-HOUR INFUSION EVERY 3 WEEKS - AN EORTC-ECSG STUDY
Authors: BRIASOULIS E JUDSON I PAVLIDIS N BEALE P GROOT Y VEERMAN G SCHUESSLER M RAMMOU D WALKER R HANAUSKE A
Citation: E. Briasoulis et al., PHASE-I TRIAL AND PHARMACOKINETICS OF BETA-D-GLUCOSYLISOPHOSPHORAMIDEMUSTARD (D-19575) ADMINISTERED AS A 6-HOUR INFUSION EVERY 3 WEEKS - AN EORTC-ECSG STUDY, Annals of oncology, 9, 1998, pp. 616-616
PHASE-I TRIAL OF WEEKLY ADMINISTRATION OF DOCETAXEL IN MINIMALLY PRETREATED CANCER-PATIENTS - A FEASIBILITY AND CUMULATIVE TOXICITY STUDY
Authors: BRIASOULIS E KARAVASILIS V ANASTASOPOULOS D FOUNTZILAS G TZAMAKOU E RAMMOU D PAVLIDIS N
Citation: E. Briasoulis et al., PHASE-I TRIAL OF WEEKLY ADMINISTRATION OF DOCETAXEL IN MINIMALLY PRETREATED CANCER-PATIENTS - A FEASIBILITY AND CUMULATIVE TOXICITY STUDY, Annals of oncology, 9, 1998, pp. 385-385
A PHASE-I TRIAL OF D19575, A BETA-D-GLUCOSE-LINKED ISOPHOSPHORAMIDE MUSTARD GIVEN AS A 6-HOUR INFUSION
Authors: BRIASOULIS E JUDSON I PAVLIDIS N BEALE P WANDERS J GROOT Y VEERMAN G LOCHER M SCHUESSLER M TZAMAKOU E RAMMOU D WOLF L WALKER R HANAUSKE A
Citation: E. Briasoulis et al., A PHASE-I TRIAL OF D19575, A BETA-D-GLUCOSE-LINKED ISOPHOSPHORAMIDE MUSTARD GIVEN AS A 6-HOUR INFUSION, Annals of oncology, 9, 1998, pp. 473-473
DOSE-DENSE SEQUENTIAL ADJUVANT CHEMOTHERAPY WITH EPIRUBICIN, PACLITAXEL AND CMF IN PATIENTS WITH OPERABLE BREAST-CANCER AND GREATER-THAN-OR-EQUAL-TO-10 POSITIVE AXILLARY NODES
Authors: FOUNTZILAS G DIMOPOULOS M PAPADIMITRIOU C ARAVANTINOS G BRIASSOULIS E BAFALOUKOS D PAPAKOSTAS P PAVLIDIS N SKARLOS D
Citation: G. Fountzilas et al., DOSE-DENSE SEQUENTIAL ADJUVANT CHEMOTHERAPY WITH EPIRUBICIN, PACLITAXEL AND CMF IN PATIENTS WITH OPERABLE BREAST-CANCER AND GREATER-THAN-OR-EQUAL-TO-10 POSITIVE AXILLARY NODES, Annals of oncology, 9, 1998, pp. 685-685
TROPISETRON IN THE PREVENTION OF ACUTE NAUSEA AND VOMITING IN PATIENTS TREATED WITH HIGH-DOSE EPIRUBICIN
Authors: NICOLAIDES C GIANNAKAKIS T SKARLOS D ATHANASSIADIS A FOUNTZILAS G DAMIGOS D PAVLIDIS N
Citation: C. Nicolaides et al., TROPISETRON IN THE PREVENTION OF ACUTE NAUSEA AND VOMITING IN PATIENTS TREATED WITH HIGH-DOSE EPIRUBICIN, Journal of experimental & clinical cancer research, 17(1), 1998, pp. 71-75
BCL2 AND P53 PROTEIN EXPRESSION IN METASTATIC CARCINOMA OF UNKNOWN PRIMARY ORIGIN - BIOLOGICAL AND CLINICAL IMPLICATIONS - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY
Authors: BRIASOULIS E TSOKOS M FOUNTZILAS G BAFALOUKOS D KOSMIDIS P SAMANTAS E SKARLOS D NICOLAIDES C PAVLIDIS N
Citation: E. Briasoulis et al., BCL2 AND P53 PROTEIN EXPRESSION IN METASTATIC CARCINOMA OF UNKNOWN PRIMARY ORIGIN - BIOLOGICAL AND CLINICAL IMPLICATIONS - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Anticancer research, 18(3B), 1998, pp. 1907-1914
PROGNOSTIC FACTORS INFLUENCING COMPLETE RESPONSE TO TREATMENT AND SURVIVAL OF PATIENTS WITH NASOPHARYNGEAL CANCER
Authors: KALOGERAFOUNTZILA A KOSMIDIS P BACOYIANNIS C NICOLAOU A SAMANTAS E BRIASSOULIS E PAVLIDIS N SKARLOS D DANILIDIS J FOUNTZILAS G
Citation: A. Kalogerafountzila et al., PROGNOSTIC FACTORS INFLUENCING COMPLETE RESPONSE TO TREATMENT AND SURVIVAL OF PATIENTS WITH NASOPHARYNGEAL CANCER, Anticancer research, 18(1B), 1998, pp. 587-593
FAVORABLE OUTCOME OF OVARIAN GERM-CELL MALIGNANCIES TREATED WITH CISPLATIN OR CARBOPLATIN-BASED CHEMOTHERAPY - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY
Authors: DIMOPOULOS MA PAPADOPOULOU M ANDREOPOULOU E PAPADIMITRIOU C PAVLIDIS N ARAVANTINOS G ASPROPOTAMITIS A ANAGNOSTOPOULOS A FOUNTZILAS G MICHALAS S PECTACIDES D
Citation: Ma. Dimopoulos et al., FAVORABLE OUTCOME OF OVARIAN GERM-CELL MALIGNANCIES TREATED WITH CISPLATIN OR CARBOPLATIN-BASED CHEMOTHERAPY - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Gynecologic oncology (Print), 70(1), 1998, pp. 70-74
DOSE-DENSE ADJUVANT CHEMOTHERAPY WITH EPIRUBICIN MONOTHERAPY IN PATIENTS WITH OPERABLE BREAST-CANCER AND GREATER-THAN-OR-EQUAL-TO-10 POSITIVE AXILLARY LYMPH-NODES - A FEASIBILITY STUDY
Authors: FOUNTZILAS GG NICOLAIDES C ARAVANTINOS G SKARLOS D KOSMIDIS P PAPAKOSTAS P STATHOPOULOS GP KONTOSTOLIS E BAFALOUKOS D PAVLIDIS N
Citation: Gg. Fountzilas et al., DOSE-DENSE ADJUVANT CHEMOTHERAPY WITH EPIRUBICIN MONOTHERAPY IN PATIENTS WITH OPERABLE BREAST-CANCER AND GREATER-THAN-OR-EQUAL-TO-10 POSITIVE AXILLARY LYMPH-NODES - A FEASIBILITY STUDY, Oncology, 55(6), 1998, pp. 508-512
DIFFUSE LARGE-CELL LYMPHOMAS - IDENTIFICATION OF PROGNOSTIC FACTORS AND VALIDATION OF THE INTERNATIONAL NON-HODGKINS-LYMPHOMA PROGNOSTIC INDEX - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY
Authors: NICOLAIDES C FOUNTZILAS G ZOUMBOS N SKARLOS D KOSMIDIS P PECTASIDES D KARABELIS A GIANNAKAKIS T SYMEONIDIS A PAPADOPOULOS A ANTONIOU F PAVLIDIS N
Citation: C. Nicolaides et al., DIFFUSE LARGE-CELL LYMPHOMAS - IDENTIFICATION OF PROGNOSTIC FACTORS AND VALIDATION OF THE INTERNATIONAL NON-HODGKINS-LYMPHOMA PROGNOSTIC INDEX - A HELLENIC COOPERATIVE ONCOLOGY GROUP-STUDY, Oncology, 55(5), 1998, pp. 405-415
COMBINATION REGIMEN WITH CARBOPLATIN, EPIRUBICIN AND ETOPOSIDE IN METASTATIC CARCINOMAS OF UNKNOWN PRIMARY SITE - A HELLENIC COOPERATIVE ONCOLOGY GROUP PHASE-II STUDY
Authors: BRIASOULIS E TSAVARIS N FOUNTZILAS G ATHANASIADIS A KOSMIDIS P BAFALOUKOS D SAMANTAS E PAVLIDIS N
Citation: E. Briasoulis et al., COMBINATION REGIMEN WITH CARBOPLATIN, EPIRUBICIN AND ETOPOSIDE IN METASTATIC CARCINOMAS OF UNKNOWN PRIMARY SITE - A HELLENIC COOPERATIVE ONCOLOGY GROUP PHASE-II STUDY, Oncology, 55(5), 1998, pp. 426-430
SUBCUTANEOUS LOW-DOSES OF INTERLEUKIN-2 AND RECOMBINANT INTERFERON-ALPHA WITH CARBOPLATIN AND VINBLASTINE IN PATIENTS WITH ADVANCED MELANOMA
Authors: BAFALOUKOS D FOUNTZILAS G SKARLOS D PAVLIDIS N BAKOYIANNIS C KARVOUNIS N KOSMIDIS P
Citation: D. Bafaloukos et al., SUBCUTANEOUS LOW-DOSES OF INTERLEUKIN-2 AND RECOMBINANT INTERFERON-ALPHA WITH CARBOPLATIN AND VINBLASTINE IN PATIENTS WITH ADVANCED MELANOMA, Oncology, 55(1), 1998, pp. 48-52
LOCAL IMMUNE-RESPONSE AFTER INTRAVESICAL INTERFERON-GAMMA IN SUPERFICIAL BLADDER-CANCER
Authors: STAVROPOULOS NE IOACHIM E PAVLIDIS N PAPPA L KALOMIRIS P AGNANTIS NJ
Citation: Ne. Stavropoulos et al., LOCAL IMMUNE-RESPONSE AFTER INTRAVESICAL INTERFERON-GAMMA IN SUPERFICIAL BLADDER-CANCER, British Journal of Urology, 81(6), 1998, pp. 875-879
PHASE-II STUDY OF INTERFERON-GAMMA (RIFN-G) AND VINBLASTINE (VBL) IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA (RCC)
Authors: BACOYIANNIS C DIMOPOULOS MA NICOLAIDES C ARAVANTINOS G XIROS N SKARLOS D PAVLIDIS N KOSMIDIS P
Citation: C. Bacoyiannis et al., PHASE-II STUDY OF INTERFERON-GAMMA (RIFN-G) AND VINBLASTINE (VBL) IN PATIENTS WITH ADVANCED RENAL-CELL CARCINOMA (RCC), European journal of cancer, 33, 1997, pp. 177-177
INTRAPERITONEAL (IP) INTERFERON A2B (INF) CONSOLIDATION IN CCR OVARIAN-CANCER (OC) PATIENTS FOLLOWING CARBOPLATIN CHEMOTHERAPY (CT)
Authors: KOSMIDIS P BAFALOUKOS D SKARLOS D PAVLIDIS N ARAVANTINOS G ATHANASIADIS A KARPATHIOS S FOUNTZILAS G
Citation: P. Kosmidis et al., INTRAPERITONEAL (IP) INTERFERON A2B (INF) CONSOLIDATION IN CCR OVARIAN-CANCER (OC) PATIENTS FOLLOWING CARBOPLATIN CHEMOTHERAPY (CT), European journal of cancer, 33, 1997, pp. 385-385
PHASE-II STUDIES WITH GI147211 (GI) IN BREAST (B), COLORECTAL (C) ANDNON-SMALL-CELL LUNG-CANCER (N)
Authors: WANDERS J HUININK WWT PAVLIDIS N KAYE SB SESSA C LEHNERT M PICCART M PARIDAENS R WISSEL P HANAUSKE AR
Citation: J. Wanders et al., PHASE-II STUDIES WITH GI147211 (GI) IN BREAST (B), COLORECTAL (C) ANDNON-SMALL-CELL LUNG-CANCER (N), European journal of cancer, 33, 1997, pp. 705-705
PRIMARY EXTRANODAL NON-HODGKINS-LYMPHOMA OF THE HEAD AND NECK (HN-NHL)
Authors: ECONOMOPOULOS T FOUNTZILAS G KOSTOUROU A DANIELIDIS J PAVLIDIS N ANDREOPOULOU E NICOLAOU A MELLOU S DERVENOULAS J STATHAKIS N
Citation: T. Economopoulos et al., PRIMARY EXTRANODAL NON-HODGKINS-LYMPHOMA OF THE HEAD AND NECK (HN-NHL), European journal of cancer, 33, 1997, pp. 1209-1209
Risultati: 1-25 | 26-50 | 51-71